國家衛生研究院 NHRI:Item 3990099045/1911

NHRI > National Institute of Infectious Diseases and Vaccinology > Monto Ho(1997-2002) > Periodical Articles > Item 3990099045/1911

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/1911

Title:	Emergence of reduced susceptibility and resistance to fluoroquinolones in Escherichia coli in Taiwan and contributions of distinct selective pressures
Authors:	McDonald, LC;Chen, FJ;Lo, HJ;Yin, HC;Lu, PL;Huang, CH;Chen, P;Lauderdale, TL;Ho, M
Contributors:	Division of Clinical Research
Abstract:	A survey of 1,203 Escherichia coli isolates from 44 hospitals in Taiwan revealed that 136 (11.3%) isolates were resistant to fluoroquinolones and that another 261 (21.7%) isolates had reduced susceptibility. Resistance was more common in isolates responsible for hospital-acquired (mostly in intensive care units) infections (17.5%) than in other adult inpatient (11.4%; P = 0.08) and outpatient isolates (11.9%; P > 0.1). Similarly, reduced susceptibility was more common in isolates responsible for hospital-acquired infections (30.9%) than in other adult inpatient (21.0%; P = 0.04) and outpatient (21.4%; P = 0.06) isolates. Isolates from pediatric patients were less likely to be resistant (1.3 versus 12.0%; P < 0.01) but were nearly as likely to have reduced susceptibility (17.7 versus 21.9%; P > 0.1) as nonpediatric isolates. There was an inverse relationship in the proportion of isolates that were resistant versus the proportion that had reduced susceptibility among isolates from individual hospitals (R = 0.031; P < 0.05). In an analysis of isolates from two hospitals, all 9 resistant strains possessed double point mutations in gyrA and all 19 strains with reduced susceptibility strains had single point mutations; no mutations were found among fully susceptible strains. Risk factors for resistance included underlying cancer (odds ratio [OR], 83; 95% confidence interval [CI95], 7.3 to 2,241; P < 0.001), exposure to a quinolone (OR, undefined; P = 0.02), and exposure to a nonquinolone antibiotic (OR, 20; CI95, 2.2 to 482; P < 0.001); underlying cancer was the only independent risk factor (OR, 83; CI95, 8.6 to 807; P < 0.001). There were no significant associations between any of these factors and reduced susceptibility. Whereas acute and chronic quinolone use in cancer patients is a major selective pressure for resistance, other undetermined but distinct selective pressures appear to be more responsible for reduced susceptibility to fluoroquinolones in E. coli.
Keywords:	Microbiology;Pharmacology & Pharmacy
Date:	2001-11
Relation:	Antimicrobial Agents and Chemotherapy. 2001 Nov;45(11):3084-3091.
Link to:	http://dx.doi.org/10.1128/AAC.45.11.3084-3091.2001
JIF/Ranking 2023:	http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=0066-4804&DestApp=IC2JCR
Cited Times(WOS):	https://www.webofscience.com/wos/woscc/full-record/WOS:000171664900016
Cited Times(Scopus):	http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0034774995
Appears in Collections:	[Monto Ho(1997-2002)] Periodical Articles [McDonald LC(1998-2000)] Periodical Articles [Tsai-Ling Yang Lauderdale] Periodical Articles [Hsiu-Jung Lo] Periodical Articles [Feng-Jui Chen] Periodical Articles

Files in This Item:

File	Description	Size	Format
000171664900016.pdf		102Kb	Adobe PDF	1032	View/Open

Loading...